Erik Churchill
Duke Medical Center(US)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Treatment of Major Depression, Tryptophan and brain disorders, Posttraumatic Stress Disorder Research, Chronic Disease Management Strategies
Most-Cited Works
- → Alterations in metabolic pathways and networks in Alzheimer’s disease(2013)208 cited
- → Derivation of the SPAN, a brief diagnostic screening test for post-traumatic stress disorder(1999)178 cited
- → Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept(2011)129 cited
- → Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo(2013)111 cited
- → Nefazodone in post-traumatic stress disorder: results from six open-label trials(1999)94 cited
- → Pharmacometabolomics of Response to Sertraline and to Placebo in Major Depressive Disorder – Possible Role for Methoxyindole Pathway(2013)90 cited
- → Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment(2013)72 cited
- → A Double-Blind Combination Study of Clonazepam with Sertraline in Obsessive-Compulsive Disorder(2004)72 cited
- → Symptom-specific effects of fluoxetine in post-traumatic stress disorder(2000)56 cited
- → Access to routine care and risks for 30-day readmission in patients with cardiovascular disease(2017)34 cited